维普期刊资源整合服务平台（V6.5）

111篇 您的检索式：作者名="GION M"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Serum CA549 in primary breast cancer: oomparison with CA15-3 and MCA显示文摘	Gion M Mione R	1994	Br J Cancer1994，69，：	1
2	Reduction of aluminum concentation in albumin products显示文摘	Inoue M Gion Y Itoh H	1994	Vox Sang1994，66，4：	1
3	Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer显示文摘	Gasparini G Gion M Mariani L	2007	Breast Cancer Res Treat2007，101，3：	1
4	Ps2 in breast cancer-alter- native oreomplementary tool to steroid receptor status7 Evaluation of 446 cases显示文摘	Gion M Mione R Pappagallo GK	1993	Br J Cancer1993，68，2：	1
5	Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma 显示文摘	Gasparini G Toi M Gion M	1997	J Nail Cancer Inst1997，89，2：	1
6	The role of telomerase activity in hepatocellular carcinoma显示文摘	Shimada M Hasegawa H Gion T	2000	Am J Gastroenterol2000，95，3：	1
7	Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume 显示文摘	Shirabe K Shimada M Gion T	1999	J Am Coil Surg1999，188，3：	1
8	Prognostic significance of vascu lar endothelial growth factor protein in node negative breast carcinoma显示文摘	Gasparini G Toi M Gion M	1997	Natl Cancer Inst1997，89，2：	1
9	The proteome of tam'i- time pine wood forming tissue显示文摘	GION J M LALANNE C LE PROVOST G	2005	Proteomics2005，5，：	1
10	Re: Biological variation of neuroendocrinetumor markers chromogranin A and neuron-specific enlace 显示文摘	Dittadi R Gion M	2013	Clin Biochem2013，，46：	1
11	Postoperative liver failure af- ter major hepatic resection for hepatocellular carcinoma in the Morden Era with special reference to remnant liver volume显示文摘	Shirabe K Shimada M Gion T	1999	J Am Coll Surg1999，188，3：	1
12	Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4- anilinoquinazolines 显示文摘	Schemer M Di Gion P Doroshyenko O	2011	Clin Pharmacokinet2011，50，：	1
13	Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time:a prospective study on 859 patients显示文摘	Gion M Peloso L Mione R	2001	Cancer J2001，7，3：	1
14	CA549 in primary breast caneer:Comparison with CA15-3 and MCA显示文摘	Gion M Plebani M Mione R	1994	Br J cancer1994，69，4：	1
15	PS-2 in breast cancer:alternative or compoementary tool to stersid receptor status? Evaluation of 446 cases显示文摘	Mione R Pappagallo GL	1993	Br J Cancer1993，68，2：	1
16	Clinical pharmacokinetics of tyrosine kinase inhibitors:focus on4-anilinoquinazolines显示文摘	Scheffler M Di Gion P Doroshyenko O	2011	Clin Pharmacokinet2011，50，6：	1
17	Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma 显示文摘	Gasparini G Toi M Gion M		J National Cancer Institute0，89，：	1
18	Treatment strategy for patients with cystic lesions mimicking a liver tumer显示文摘	Shmada M Takenaka K Gion T	1998	Archives of Surgery1998，133，6：	1
19	The role of telomerase activity in hepatocellular carcinoma显示文摘	Shimada M Hastgawa H Gion T	2000	Am J Gastroenterol2000，95，3：	1
20	The role of telomerase activity in hepatocellular carcinoma显示文摘	Shimada M Hasegawa H Gion T	2000	Am J Gastroenterol2000，95，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示